Literature DB >> 7883779

TP53 gene mutations in gastric carcinoma detected by polymerase chain reaction/single-strand conformation polymorphism analysis of archival material.

E D'Andrea1, R Baffa, C Menin, M Montagna, M Rugge, L Chieco-Bianchi.   

Abstract

TP53 gene mutations, one of the most common alterations described in human tumors, have also been detected in gastric carcinoma, and shown to occur rather late in disease progression. A better assessment of the prognostic value of TP53 gene mutations can be obtained by examining archival material, as this allows stored cases with well-defined histories to be monitored. We performed immunohistochemical and polymerase chain reaction/single-strand conformation polymorphism (PCR-SSCP) analyses of formalin-fixed paraffin-embedded material from nine selected cases of gastric carcinoma at different pathological stages. PCR-SSCP analysis of TP53 exons 5-8 detected missense point mutations in two out of five immunostain(PAb1801)-positive tumors, and a deletion (allowing for a premature stop codon) in one of the remaining four immunostain-negative tumors. Thus, PCR-SSCP analysis represents a feasible strategy for the detection of TP53 alterations in archival material of gastric carcinoma cases.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7883779     DOI: 10.1007/bf01202217

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  34 in total

1.  P53 in tumour pathology: can we trust immunocytochemistry?

Authors:  D Wynford-Thomas
Journal:  J Pathol       Date:  1992-04       Impact factor: 7.996

2.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction.

Authors:  M Orita; Y Suzuki; T Sekiya; K Hayashi
Journal:  Genomics       Date:  1989-11       Impact factor: 5.736

3.  A simple method for isolation of DNA from formalin-fixed paraffin-embedded samples for PCR.

Authors:  P Kallio; S Syrjänen; A Tervahauta; K Syrjänen
Journal:  J Virol Methods       Date:  1991-11       Impact factor: 2.014

4.  Occurrence of p53 gene abnormalities in gastric carcinoma tumors and cell lines.

Authors:  J H Kim; T Takahashi; I Chiba; J G Park; M J Birrer; J K Roh; H De Lee; J P Kim; J D Minna; A F Gazdar
Journal:  J Natl Cancer Inst       Date:  1991-07-03       Impact factor: 13.506

5.  Short direct repeats flanking deletions, and duplicating insertions in p53 gene in human cancers.

Authors:  N Jego; G Thomas; R Hamelin
Journal:  Oncogene       Date:  1993-01       Impact factor: 9.867

Review 6.  Genetic alterations in human gastric cancer.

Authors:  S Hirohashi; T Sugimura
Journal:  Cancer Cells       Date:  1991-02

7.  Mutational hotspot in the p53 gene in human hepatocellular carcinomas.

Authors:  I C Hsu; R A Metcalf; T Sun; J A Welsh; N J Wang; C C Harris
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

8.  Abnormal expression of wild type p53 protein in normal cells of a cancer family patient.

Authors:  D M Barnes; A M Hanby; C E Gillett; S Mohammed; S Hodgson; L G Bobrow; I M Leigh; T Purkis; C MacGeoch; N K Spurr
Journal:  Lancet       Date:  1992-08-01       Impact factor: 79.321

Review 9.  TP53 tumor suppressor gene: a model for investigating human mutagenesis.

Authors:  C Caron de Fromentel; T Soussi
Journal:  Genes Chromosomes Cancer       Date:  1992-01       Impact factor: 5.006

10.  High incidence of nuclear accumulation of p53 protein in gastric cancer.

Authors:  S Uchino; M Noguchi; T Hirota; M Itabashi; T Saito; M Kobayashi; S Hirohashi
Journal:  Jpn J Clin Oncol       Date:  1992-08       Impact factor: 3.019

View more
  1 in total

1.  Evidence that expression of a mutated p53 gene attenuates apoptotic cell death in human gastric intestinal-type carcinomas in vivo.

Authors:  M Ishida; Y Gomyo; S Ohfuji; M Ikeda; H Kawasaki; H Ito
Journal:  Jpn J Cancer Res       Date:  1997-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.